• 2019 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2019 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    March 28-30, 2019, Chicago Hilton, Chicago, IL.

    Earn up to 11.5 CNE hours.


    Find out more about it and REGISTER today!

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2018.

    Get started... nominate today!

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations!

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2019 National Board of Directors? Register online NOW by April 1, 2019!

    Step Up - NOW is the Time! Register Here>

  • FREE continuing education credit is available for the following session:

    "Keynote Address - Health Policy: APRNs Working to the Full Extent of the Law"

    (session captured at the GAPNA 2018 Annual Conference)

    For March/April 2019 - Get Your Free CNE Now!

  • Poster Presentation


    This 22-module curriculum provides a basic knowledge base for Nurse Practitioners who looking to advance their expertise in caring for patients with dementia.

    FREE to GAPNA members until September 1, 2019

  • GAPNA Exchange


    GAPNA Exchange is a private, secure community for members to share ideas, ask questions, lend expertise, and network with peers.

    It features both an Open Forum discussion area along with smaller, segmented communities.

    Interact with GAPNA members wherever and whenever!

    Go to GAPNA Exchange

Study Results Argue Against Decisions About Screening Colonoscopy Based on Age Alone

The likely value of screening colonoscopy (SC) depends not just on the age and sex of the patient, but also on the number of co-morbidities a person has, according to a new study.

Initial guidelines for cancer screening, including SC to detect early-stage colorectal cancer (CRC), did not recommend an upper age limit for screening.

In 2008 the United States Preventive Services Task Force recommended against routine SC in patients 76-85 years old, and against any screening for CRC in patients older than 85.

The task force based its recommendations on diminishing benefit of SC with increasing age.

Researches in a new study found that taking into account the number of co-morbidities affected whether a patient was likely to benefit from SC, even after accounting for age.

For both men and women aged 85-94 with no co-morbidities, SC is estimated to save around 100 life-years per 100,000 patients screened (65 life-years for men, 111 life-years for women).

However, for men and women with at least three co-morbidities, there were no life-years saved for patients older than 74.

For more info, see Gross et al. (2011). Assessing the impact of screening colonoscopy on mortality in the Medicare population. Journal of General Internal Medicine, 26(12), 1441-1449.

Related Topic 1: 

GAPNA Newsletter Issue: